PS101 Chapter Notes -Agoraphobia, Electroconvulsive Therapy, Therapeutic Relationship
Document Summary
Contemporary view alternates between mental disorders as diseases (medical treatment) and emotional problems (psychological treatment) Drug treatments on the rise with growing recognition of biological and genetic components to disorders. Medications that alter the production of or response to neurotransmitters in the brain. Drugs used primarily in the treatment of schizophrenia and other psychotic disorders. Most designed to block or reduce the sensitivity of brain receptors that respond to dopamine. Side effects such as muscular rigidity (hardness), tremors, and involuntary muscle movements (tardive dyskinesia) Drugs used primarily in the treatment of mood disorders, especially depression and anxiety. Produce unpleasant physical reactions (dry mouth, headache, nausea, constipation, weight gain, restlessness) Drugs commonly but often inappropriately prescribed for patients who complain of unhappiness, anxiety, or worry. Drug frequently given to people suffering from bipolar disorder (moderates norepinephrine and stops overstimulation from glutamate)
